Printer Friendly
The Free Library
14,599,499 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amgen continues buy-back.


Directors at biotech giant Amgen Inc. last week authorized an additional repurchase of up to $5 billion in its common stock, a vote of confidence in the company's long-term prospects even as others are questioning the long-term profitability of its flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation.  line.

The Thousand Oaks Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown.  company, which had $1.5 billion remaining under its previous stock buyback Stock buyback

A corporation's purchase of its own outstanding stock, usually in order to raise the company's earnings per share.


stock buyback

See buyback.
 authorization, has seen its Epogen-Aranesp anemia treatments come under fire in recent weeks. A congressional panel earlier this month discussed whether to change how dialysis centers and doctors are reimbursed for prescribing Epogen in conjunction with kidney dialysis Dialysis, Kidney Definition

Dialysis treatment replaces the function of the kidneys, which normally serve as the body's natural filtration system.
, which often leads to anemia.

Staff reporter Deborah Crowe can be reached at (323) 549-5255, ext. 232, or at dcrowe@labusinessjournal.com.
COPYRIGHT 2006 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ADDICTION
Author:Crowe, Deborah
Publication:Los Angeles Business Journal
Date:Dec 18, 2006
Words:118
Previous Article:Vision plan gets license.(ADDICTION)
Next Article:Diamond deal puts brighter shine on Internet ad company: Spot Runner signs contract for promotion of gems.(Spot Runner)
Topics:



Related Articles
Amgen to Buy Back Stock.
IN BRIEF.(BUSINESS)
AMGEN INCOME BEATS FORECAST.(BUSINESS)
BIZWATCH : MARKETS.(BUSINESS)
AMGEN ANNOUNCES $1 BILLION BUYBACK.(BUSINESS)(Statistical Data Included)
Amgen's debt offering has many investors taking note. (Wall Street West).(Amgen reports $2.5 bn from new offering)(Statistical Data Included)
Amgen has right prescription for sales of blockbuster drugs. (Up Front).
Drugstore cowboys.(Investments & Finance)(Amgen Inc. looking for drugs to develop)
Stock buyback, patent victory give bounce to Amgen shares.(Corporate Focus)
AMGEN PROFITS ENJOY NEW ZIP ANEMIA DRUG ADDS VIGOR TO EARNINGS.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles